Stage C, Dalhoff K, Rasmussen HB, Schow Guski L, Thomsen R, Bjerre D, Ferrero-Miliani L, Busk Madsen M, Jurgens G (2019)
The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios
Basic Clin Pharmacol Toxicol 125: 54

Stage C, Jurgens G, Guski LS, Thomsen R, Bjerre D, Ferrero-Miliani L, Lyauk YK, Rasmussen HB, Dalhoff K (2017)
The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects
British Journal of Clinical Pharmacology 83: 1506

Stage C, Jurgens G, Guski LS, Thomsen R, Bjerre D, Ferrero-Miliani L, Lyauk YK, Rasmussen HB, Dalhoff K (2017)
The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers
Basic Clin Pharmacol Toxicol 121: 487

Rasmussen HB, Bjerre D, Linnet K, Jurgens G, Dalhoff K, Stefansson H, Hankemeier T, Kaddurah-Daouk R, Taboureau O, Brunak S, Houmann T, Jeppesen P, Pagsberg AK, Plessen K, Dyrborg J, Hansen PR, Hansen PE, Hughes T, Werge T (2015)
Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics
Pharmacogenomics 16: 649